New research reveals that payments to Medicare Advantage brokers have more than doubled in just eight years, reaching over $10 billion annually.
New research published as a JAMA Internal Medicine study has provided one of the clearest pictures yet on the size of the Medicare Advantage insurance broker market. Health policy scholars from Brown University School of Public Health found that payments to these brokers have more than doubled since 2014, rising from approximately $3.9 billion in 2014 to nearly $10 billion annually by 2022. This substantial increase underscores the growing importance and scale of the Medicare Advantage broker industry.
The study highlights a significant shift in how beneficiaries access Medicare Advantage plans, with brokers playing an increasingly crucial role in helping individuals navigate the complex healthcare landscape. As these payments have grown so dramatically over such a short period, it raises questions about potential conflicts of interest and the overall cost-effectiveness of this intermediary service within the Medicare system.
Moreover, the findings suggest that policymakers may need to reevaluate their strategies for managing the Medicare Advantage market, considering the substantial financial influence exerted by brokers on beneficiaries' healthcare choices. As more data becomes available, it is hoped that these insights will contribute to informed discussions about how best to support both consumers and providers in this evolving health insurance ecosystem.
